In this review, we summarize the related knowledge and results about the expression, biological functions, and immunotherapy studies of disialogangliosides GD3 and GD2 as well as GD3S in cancers, providing the possibility of gangliosides and GD3 synthase as therapeutic targets in cancer treatment. Here, ST8SIA1 is linked to cancer.